miRecule and GBI Biomanufacturing Announce Strategic Partnership to Advance Development of Antibody RNA Conjugate (ARC) Therapies

PLANTATION, Fla. and GAITHERSBURG, Md., Jan. 28, 2025 /PRNewswire/ — miRecule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading contract development and manufacturing organization (CDMO), today announced a strategic partnership to advance the…